Blueprint Medicines (BPMC)
(Delayed Data from NSDQ)
$104.96 USD
-1.68 (-1.58%)
Updated May 17, 2024 04:00 PM ET
After-Market: $104.88 -0.08 (-0.08%) 4:26 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-1.30 | 0.00% |
Earnings Summary
For their last quarter, Blueprint Medicines (BPMC) reported earnings of -$1.32 per share, beating the Zacks Consensus Estimate of $-1.64 per share. This reflects a positive earnings surprise of 19.51%. Look out for BPMC's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$1.30 per share, reflecting a year-over-year increase of 40.64%.
Earnings History
Price & Consensus
Zacks News for BPMC
PetIQ (PETQ) Gears Up to Report Q1 Earnings: What's in Store?
BPMC: What are Zacks experts saying now?
Zacks Private Portfolio Services